Kodal, Arne
Muirhead, Fiona
Reilly, John J.
Wergeland, Gro Janne H.
Thorsen, Paul Joachim Bloch
Bovim, Lars Peder
Elgen, Irene Bircow
Article History
Received: 28 September 2021
Accepted: 18 February 2022
First Online: 2 March 2022
Declarations
:
: Ethical approval for the study was received from the Regional Committee for Medical and Health Research Ethics, region West, Norway (no. 30912 REK Vest). Informed written consent is obtained from all parents, and assent is obtained from youth above age 12 years. Personal confidentiality is guaranteed. None of the assessments are considered to involve any health risk, and we believe most adolescents will benefit from participation in the CAH-Y intervention. Those who do not benefit will still have standard care follow-up in CAMHS. The letter of informed consent emphasizes the participants’ right to withdraw from the project at any time, with no need for any explanation.
: Not applicable.
: The authors declare that they have no competing interests.